Searchable Patents Journal

Search details
          Search details help

   Results per page

Currently viewing: Intellectual Property Office - Patents Journal : SPCs
From 2015 May 27th - 6575 to 2015 May 27th - 6575
Refine: 

  • Help on this tab
    • Page
    • Previous
    • 1
    • Next
Publication
Date
SPC No.SPC
Category
Details
Rows may repeat to show multiple inventors or applicants depending on "Sort By"
27 May 2015
(Journal 6575)
SPC/GB02/001Entered Into ForceApplicant: Aventis Pharma S.A.
20 Avenue Raymond Aron, F-92160, Antony, France

Product: Telithromycin and addition salts thereof with pharmaceutically acceptable acids

Product Type: Medicinal
Authorised: UK EU/1/01/191/001-004 10 July 2001

Authorised Extension:

Patent No: EP0680967
Title: Erythromycin derivatives, their process of preparation and their uses as medicaments

SPC No: SPC/GB02/001
Date entered into force: 2 May 2015
Effective Period Expires On: 9 July 2016
27 May 2015
(Journal 6575)
SPC/GB06/009Entered Into ForceApplicant: Pharmacia & Upjohn Company LLC
Kalamazoo, Michigan 49001, USA

Product: [R-(R*,R*)]-N-[3-[1-[5,6-dihydro-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-2H-pyran-3-yl]propyl]phenyl]-5-(trifluoromethyl)-2-pyridinesulfonamide or a pharmaceutical salt thereof = (Tipranavir or a pharmaceutical salt thereof)

Product Type: Medicinal
Authorised: CH 57330 25 August 2005
UK EU/1/05/315/001 25 October 2005

Authorised Extension:

Patent No: EP0758327
Title: Pyranone compounds useful to treat retroviral infections

SPC No: SPC/GB06/009
Date entered into force: 4 May 2015
Effective Period Expires On: 3 May 2020
27 May 2015
(Journal 6575)
SPC/GB10/015Entered Into ForceApplicant: Alexion Pharmaceuticals, Inc
Cheshire, CT06410, USA

Product: Eculizumab

Product Type: Medicinal
Authorised: UK EU/1/07/393/001 20 June 2007

Authorised Extension:

Patent No: EP0758904
Title: Methods and compositions for the treatment of glomerulonephritis

SPC No: SPC/GB10/015
Date entered into force: 1 May 2015
Effective Period Expires On: 30 April 2020
27 May 2015
(Journal 6575)
SPC/GB15/026LodgedApplicant: Nektar Therapeutics
455 Mission Bay, Boulevard South, Suite 100, San Francisco, CA 94158 USA

Product: MOVENTIG which is the oxylate salt of the alpha-epimer of naloxegol

Product Type: Medicinal
Authorised: UK EU/1/14/962 8 December 2014

Authorised Extension:

Patent No: EP1694363
Title: Monodisperse PEGylated naloxol compositions

SPC No: SPC/GB15/026
Date Lodged: 28 April 2015
  • Page 1 of 1 (4 hits)
  • Page
  • Previous
  • 1
  • Next

Tell us about a problem